This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Inhibrx Biosciences, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Florian Sulzmaier: Innovator in Therapeutic Polypeptides
Introduction
Florian Sulzmaier is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic polypeptides. With a total of 2 patents, his work focuses on innovative solutions for treating diseases.
Latest Patents
Florian's latest patents include "OX40-binding polypeptides and uses thereof" and "PD-1 single domain antibodies and therapeutic compositions thereof." The first patent provides VHH-containing polypeptides that bind OX40, with applications in agonizing OX40 for therapeutic purposes. The second patent details binding polypeptides that specifically target PD-1, including fusion proteins and pharmaceutical compositions aimed at treating conditions such as cancer.
Career Highlights
Florian is currently associated with Inhibrx Biosciences, Inc., where he continues to advance his research and development efforts. His work is instrumental in creating innovative therapeutic options that can significantly impact patient care.
Collaborations
Florian collaborates with notable colleagues, including John C Timmer and Brendan P Eckelman, to further enhance the scope and impact of his research.
Conclusion
Florian Sulzmaier's contributions to the field of biotechnology through his patents and collaborative efforts highlight his role as an influential inventor. His work in therapeutic polypeptides is paving the way for new treatments in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile